Human Immunodeficiency Virus type 1 (HIV-1) infection induces neurological and neuropsychological deficits, which are associated with dysregulation of the medial prefrontal cortex (mPFC) and other vulnerable brain regions. We evaluated the impact of HIV infection in the mPFC and the therapeutic potential of targeting overactive voltage-gated L-type Ca 2+ channels (L-channel) and NMDA receptors (NMDAR), as modeled in HIV-1 transgenic (Tg) rats. Whole-cell patch-clamp recording was used to assess the membrane properties and voltage-sensitive Ca 2+ potentials (Ca 2+ influx) in mPFC pyramidal neurons. Neurons from HIV-1 Tg rats displayed reduced rheobase, spike amplitude and inwardly-rectifying K + influx, increased numbers of action potentials, and a trend of aberrant firing compared to those from non-Tg control rats. Neuronal hyper-excitation was associated with abnormally-enhanced Ca 2+ influx (independent of NMDAR), which was eliminated by acute L-channel blockade. Combined chronic blockade of over-active L-channels and NMDARs with open-channel blockers abolished HIV effects on spiking, aberrant firing and Ca 2+ potential half-amplitude duration, though not the reduced inward rectification. In contrast, individual chronic blockade of over-active L-channels or NMDARs did not alleviate HIV-induced mPFC hyper-excitability. These studies demonstrate that HIV alters mPFC neuronal activity by dysregulating membrane excitability and Ca 2+ influx through the L-channels. This renders these neurons more susceptible and vulnerable to excitatory stimuli, and could contribute to HIV-associated neuropathogenesis. Combined targeting of over-active L-channels/NMDARs alleviates HIV-induced dysfunction of mPFC pyramidal neurons, emphasizing a potential novel therapeutic strategy that may effectively decrease HIV-induced Ca 2+ dysregulation in the mPFC.
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Introduction
The introduction of combined antiretroviral therapy (cART) transformed HIV from a death sentence to a chronic disease with several co-morbid complications, including HIV-Associated Neurocognitive Disorders (HAND) (Antinori et al., 2007) . Despite cART, HAND affects 50% of HIV-infected individuals (Heaton et al., 2010; Simioni et al., 2010) and its prevalence is expected to increase as the HIV-infected population ages. This underscores the need to elucidate cellular/molecular mechanisms driving HIV-mediated neuropathogenesis to devise effective strategies that prevent and/or treat HAND.
HIV affects many brain regions, including the vulnerable medial prefrontal cortex (mPFC) (Ferris et al., 2008) , a key regulator of cognition, emotion and motivation-driven behavior, from which glutamatergic pyramidal neurons (80-90% of mPFC neurons) (Yuste, 2005) provide excitatory inputs to the HIV-vulnerable striatum and midbrain (Ferris et al., 2008; Sesack et al., 1989) . Although neurons are not infected, HIV-infected leukocytes invade the brain where the virus is transmitted to glial cells, which release neurotoxic viral proteins and inflammatory molecules that cause neuronal dysregulation, injury and loss. Such neuronal dysfunction involves Ca 2+ dysregulation, excitotoxicity, oxidative stress, and mitochondrial dysfunction, but the cellular/molecular mechanisms underlying these pathogenic cascades are not fully understood (Mattson et al., 2005 
